Complete Remission of Bone Metastases in Renal Cell Carcinoma With Nivolumab

Cureus
doi 10.7759/cureus.5531
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Cureus, Inc.

Related search

Complete Remission of Metastatic Melanoma With Nivolumab and Complete Remission of Hepatitis C With Ledipasvir

Cancer therapy & Oncology International Journal
2017English

Xp11.2�translocation Renal Cell Carcinoma With Multiple Bone Metastases: A Case Report

Oncology Letters
Cancer ResearchOncology
2016English

Prognostic Significance of Bone Metastases and Bisphosphonate Therapy in Patients With Renal Cell Carcinoma

European Urology
Urology
2014English

Unclassified Renal Cell Carcinoma With Significant Response to Nivolumab

Clinical Genitourinary Cancer
OncologyUrology
2017English

Nivolumab in Treatment of Renal Cell Carcinoma During Renal Replacement Therapy

Oncology in Clinical Practice
Oncology
2019English

Immunomodulatory Activity of Nivolumab in Metastatic Renal Cell Carcinoma

Clinical Cancer Research
Cancer ResearchOncology
2016English

Nivolumab in the Treatment of Advanced Renal Cell Carcinoma

Oncology in Clinical Practice
Oncology
2019English

Concomitant Oral Tyrosine Kinase Inhibitors and Bisphosphonates in Advanced Renal Cell Carcinoma With Bone Metastases

British Journal of Cancer
Cancer ResearchOncology
2012English

Vitiligo Adverse Event Observed in a Patient With Durable Complete Response After Nivolumab for Metastatic Renal Cell Carcinoma

Frontiers in Oncology
Cancer ResearchOncology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy